Adherence to Oral Disease Modifying Therapies in Clinical Practice and Patient-Centered Outcomes
Background: There are more than 20 disease modifying therapies (DMTs) approved for treatment of Multiple Sclerosis. Previous studies in the...
Direct Cost Associated with Multiple Sclerosis and Important Components; A Population-Based Study 1997-2017
Direct cost associated with Multiple sclerosis: A Population-Based Study 1997-2017 Background: Multiple sclerosis (MS) is a chronic...
An Update on Participants in the Iconquerms Network.
Background: iConquerMS is a multiple sclerosis (MS) participant-powered research network (PPRN), dedicated to engaging people affected by...
Regional MS Summit to Improve Access to High Quality MS Care
Background: In 2006, the Greater Northwest Healthcare Provider Council (HPC) of the National Multiple Sclerosis Society (NMSS) identified a...
The Influence of Tethered and Joint HCP and Patient Education on Clinical Practice Behavior, Patient Activation, and Empowerment
Background: Advances in disease-modifying therapies (DMT) for multiple sclerosis (MS) have left clinicians challenged to incorporate DMTs,...